Hutchmed Ls 1 Stock Working Capital
| H7T2 Stock | EUR 2.72 0.10 3.55% |
HUTCHMED LS 1 fundamentals help investors to digest information that contributes to HUTCHMED's financial success or failures. It also enables traders to predict the movement of HUTCHMED Stock. The fundamental analysis module provides a way to measure HUTCHMED's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HUTCHMED stock.
HUTCHMED |
HUTCHMED LS 1 Company Working Capital Analysis
HUTCHMED's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, HUTCHMED LS 1 has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
HUTCHMED Fundamentals
| Return On Equity | -0.25 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (0.64) % | |||
| Operating Margin | (0.95) % | |||
| Shares Outstanding | 864.77 M | |||
| Shares Owned By Insiders | 44.52 % | |||
| Shares Owned By Institutions | 54.43 % | |||
| Revenue | 400.81 M | |||
| Gross Profit | (201.19 M) | |||
| EBITDA | (373.29 M) | |||
| Net Income | (178.43 M) | |||
| Cash And Equivalents | 950.45 M | |||
| Cash Per Share | 1.13 X | |||
| Total Debt | 36.69 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 4.41 X | |||
| Book Value Per Share | 0.95 X | |||
| Cash Flow From Operations | (105.01 M) | |||
| Earnings Per Share | (0.23) X | |||
| Number Of Employees | 2.11 K | |||
| Beta | 0.89 | |||
| Market Capitalization | 2.91 B | |||
| Z Score | 47.4 |
About HUTCHMED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED LS 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED LS 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HUTCHMED Stock
HUTCHMED financial ratios help investors to determine whether HUTCHMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED security.